[Use of dexamethasone as an antiemetic in patients with breast cancer treated with the CMF regimen].

The antiemetic efficacy of dexamethasone (Dexaven) was examined in patients with breast cancer during chemotherapy CMF (cyclophosphamide, methotrexate and 5-fluorouracil) in comparison with patients treated identically but without dexamethasone. Comparison of the revealed statistically significant lower nausea incidence (p < 0.025) and lower vomiting incidence (p < 0.

[Influence of brachytherapy on the behavior of immunologic circulating complexes in the blood serum of patients with cervix cancer].

Applying the EA and EAC rosettes production inhibition method the appearance and levels of immunologic circulating complexes (CI) in the blood serum of 32 patients with cancer of the uterine cervix and in 100 healthy persons have been evaluated. Immunocomplexes have been examined prior to the initiation of brachytherapy and after three successive applications of radioactive cesium isotope (137Cs). Three successive application of the radioisotope contained and in the uterine probe have been used and a dose up to 2000 cGy in 16-18 hours given on each application.

[Circulating immune complexes in the blood serum of patients with untreated cervical cancer--their occurrence and quantitative analysis].

Circulating immunological complexes (KI) are one of the parameters of humoral immunity. The occurrence of KI was found in the course of neoplastic diseases both in animals and humans. They are formed as a result of interaction of neoplastic antigens with specific tumor antibodies.

[Occurrence of circulating immune complexes in the blood serum of patients with cervical cancer prior to treatment].

In the blood serum of 71 patients before treatment with cervical carcinoma and in 100 healthy women from the health services working staff, the occurrence of circulating immunologic complexes (CI) has been estimated applying the rosette EA and EAC inhibition test. The presence of CI has been proved and the frequency of positive results increases together with the stage of advancement of the neoplastic process. It appears that the CI examination should be regarded as a significant parameter in monitoring the course of treatment.